Gerard P. Zambetti
Affiliations: | Cell Biology and Biochemistry | University of Tennessee Health Science Center, Memphis, TN, United States |
Area:
Cell Biology, Biochemistry, Molecular BiologyGoogle:
"Gerard Zambetti"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pinto EM, Ribeiro EMSF, Wang J, et al. (2023) Clinical and functional analysis of the germline TP53 p.K164E acetylation site variant. Cold Spring Harbor Molecular Case Studies |
| Pinto EM, Fridman C, Figueiredo BC, et al. (2023) Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility. Hgg Advances. 5: 100244 |
| Murphy AJ, Cheng C, Williams J, et al. (2023) The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q Study. Research Square |
| Pinto EM, Rodriguez-Galindo C, Lam CG, et al. (2021) Adrenocortical Tumors in Children With Constitutive Chromosome 11p15 Paternal Uniparental Disomy: Implications for Diagnosis and Treatment. Frontiers in Endocrinology. 12: 756523 |
| Jeffers JR, Pinto EM, Rehg JE, et al. (2021) The Common Germline TP53-R337H Mutation is Hypomorphic and Confers Incomplete Penetrance and Late Tumor Onset in a Mouse Model. Cancer Research |
| Pinto EM, Zambetti GP. (2020) What 20 years of research has taught us about the TP53 p.R337H mutation. Cancer |
| Powers J, Pinto EM, Barnoud T, et al. (2020) A rare TP53 mutation predominant in Ashkenazi Jews confers risk of multiple cancers. Cancer Research |
| Pinto EM, Faucz FR, Paza LZ, et al. (2020) Germline Variants in Phosphodiesterase Genes and Genetic Predisposition to Pediatric Adrenocortical Tumors. Cancers. 12 |
| Quinn EA, Maciaszek JL, Pinto EM, et al. (2019) From uncertainty to pathogenicity: Clinical and functional interrogation of a rare TP53 in-frame deletion. Cold Spring Harbor Molecular Case Studies |
| Hu D, Jablonowski C, Cheng PH, et al. (2018) KDM5A Regulates a Translational Program that Controls p53 Protein Expression. Iscience. 9: 84-100 |